Outcomes of Surgical Management for Patent Ductus Arteriosus in Infants in Nigeria

Tex Heart Inst J. 2022 Nov 1;49(6):e217633. doi: 10.14503/THIJ-21-7633.

Abstract

Background: Patent ductus arteriosus is a common cardiac anomaly in infants that, if untreated, is associated with high morbidity and mortality rates. In lower-middle-income countries, such as Nigeria, obtaining cardiovascular surgical care for infants remains difficult. In recent years, especially with the assistance of international voluntary cardiac organizations, efforts have increased to provide cardiac surgical services to this underserved population.

Methods: In this case series, the authors describe outcomes in 30 infants surgically treated for patent ductus arteriosus between 2013 and 2019 at an emerging cardiac center in Nigeria (9 male [30%] and 21 female [70%]; mean [SD] age, 8.2 [3.01] months; mean [SD] weight, 5.3 [1.52] kg; mean [range] weight deficit, 34.5% [15%-60%]).

Results: All the infants presented with patent ductus arteriosus as the main cardiac lesion, and 4 (13%) were syndromic. The mean (SD) patent ductus arteriosus diameter was 4.73 (1.46) mm. Surgical closure was completed in 29 infants; 1 died before surgery. No procedure-related deaths occurred, but 2 cases of trivial residual patent ductus arteriosus were recorded.

Conclusion: Overall, surgical outcomes were excellent, with acceptable mortality rates. Perioperative care will continue to improve as the center is built to a self-sustaining capacity. Findings of this research at this emerging cardiac center in a developing country are a testament to the positive contribution made by international voluntary cardiac missions.

Keywords: Ligation; ductus arteriosus, patent; failure to thrive.

MeSH terms

  • Cardiac Surgical Procedures* / adverse effects
  • Child
  • Ductus Arteriosus, Patent* / surgery
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Premature
  • Male
  • Nigeria
  • Treatment Outcome

Grants and funding

Funding/Support: None